CAMBRIDGE, Mass.--(BUSINESS WIRE)--Curis, Inc. (NASDAQ: CRIS), a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that the Company will be presenting at Rodman & Renshaw’s 10th Annual Healthcare Conference, at 3:15 p.m. EST on November 11, 2008, at the Palace Hotel in New York, New York.
